GEN Exclusives

More »

Best of the Web

More »
Aug 01, 2008 (Vol. 28, No. 14)

RNA Editing Website

URL:dna.kdna.ucla.edu/rna/index.aspx
  • Descriptions
  • Too narrow
Speaking of RNA modifications, RNA editing, a subset of the phenomenon, is a bizarre but simultaneously amazing topic. Known in organisms across the eukaryotic evolutionary tree, the process involves post-transcriptional modification of RNAs, usually to alter the coding of mRNAs, but other examples exist. This includes insertional events (kinetoplastid and Physarum mitochondria), chemical modification (plant mitochondria and chloroplasts, as well as human intestines), and substitution editing in tRNAs (marsupial mitochondria). Remarkably, the changes brought by many of the modifications could probably more easily evolve by simply mutating the DNA as necessary. Why, then, does such a system exist? That’s a bigger question than I’ll try to answer here, but I will point readers to the informative RNA Editing Website, hosted by Larry Simpson at UCLA, where they can read about all these alterations and also meander from there through other sites of the RNA Webring, of which the RNA Editing Website is a member.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?